Integrins are transmembrane receptors that facilitate cell-ECM adhesion. They play a pivotal role in signaling pathways that regulate cell survival, proliferation, and migration. In cancer, integrins can be overexpressed or altered, contributing to enhanced tumor cell migration and invasion. Targeting integrins has emerged as a potential therapeutic strategy in cancer treatment.
